Other NICE updates

Mentioned previously but still ongoing – NICE are producing guidance on using cladribine tablets for treating relapsing-remitting multiple sclerosis in the NHS in England. They are inviting organisations to take part in the appraisal to produce the guidance; to submit evidence, nominate experts, comment on consultation documents produced during the appraisal, and appeal against the final recommendation. More details here:


NICE are also updating or developing guidelines on the following topics: